{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:11:16Z","timestamp":1778749876872,"version":"3.51.4"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NW24-03-00101"],"award-info":[{"award-number":["NW24-03-00101"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.prp.2025.156011","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:40:43Z","timestamp":1747122043000},"page":"156011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lysine demethylases and cancer"],"prefix":"10.1016","volume":"271","author":[{"given":"Tomas","family":"Eckschlager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ales","family":"Vicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Frolikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156011_bib1","series-title":"Twelfth edition","article-title":"Devita, Hellman, and Rosenberg\u2019s cancer: principles and practice of oncology","author":"DeVita","year":"2023"},{"key":"10.1016\/j.prp.2025.156011_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12032-023-02138-y","article-title":"Cancer chemoresistance and its mechanisms: associated molecular factors and its regulatory role","volume":"40","author":"Kannampuzha","year":"2023","journal-title":"Med Oncol."},{"key":"10.1016\/j.prp.2025.156011_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prp.2025.156011_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156011_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13148-021-01069-7","article-title":"Advances in epigenetic therapeutics with focus on solid tumors","volume":"13","author":"Jin","year":"2021","journal-title":"Clin. Epigenet"},{"key":"10.1016\/j.prp.2025.156011_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/genes12071000","article-title":"Role of histone methylation in maintenance of genome integrity","volume":"12","author":"Mushtaq","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.prp.2025.156011_bib7","first-page":"1","article-title":"Lysine demethylation in pathogenesis","volume":"1433","author":"Cao","year":"2023"},{"key":"10.1016\/j.prp.2025.156011_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110392","article-title":"Emerging of lysine demethylases (KDMs): from pathophysiological insights to novel therapeutic opportunities","volume":"129","author":"Arifuzzaman","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2025.156011_bib9","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/med.21955","article-title":"The role and prospect of lysine-specific demethylases in cancer chemoresistance","volume":"43","author":"Song","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.prp.2025.156011_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s12885-023-10923-1","article-title":"Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric cancer","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2025.156011_bib11","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1158\/0008-5472.CAN-06-1570","article-title":"Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half lim domain protein 2 predict risk of prostate cancer recurrence","volume":"66","author":"Kahl","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2025.156011_bib12","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/0008-5472.CAN-08-1735","article-title":"Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy","volume":"69","author":"Schulte","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2025.156011_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","article-title":"The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 Leukemia stem cells","volume":"21","author":"Harris","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2025.156011_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nm.2661","article-title":"Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia","volume":"18","author":"Schenk","year":"2012","journal-title":"Nat. Med"},{"key":"10.1016\/j.prp.2025.156011_bib15","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1158\/1078-0432.CCR-14-0072","article-title":"Reversible LSD1 inhibition interferes with global EWS\/ETS transcriptional activity and impedes ewing sarcoma tumor growth","volume":"20","author":"Sankar","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2025.156011_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41419-021-04297-0","article-title":"Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade","volume":"12","author":"Han","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2025.156011_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cell.2009.05.050","article-title":"LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156011_bib18","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1073\/pnas.0711865105","article-title":"Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process","volume":"105","author":"Pfau","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156011_bib19","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1172\/JCI68642","article-title":"KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1\/2 signaling","volume":"123","author":"Wagner","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2025.156011_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41416-020-01112-z","article-title":"Lysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth","volume":"124","author":"Chen","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.156011_bib21","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1182\/blood-2010-10-312736","article-title":"KDM2b\/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia","volume":"117","author":"He","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.prp.2025.156011_bib22","first-page":"JCI64535","article-title":"KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs","author":"Tzatsos","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2025.156011_bib23","doi-asserted-by":"crossref","first-page":"37091","DOI":"10.18632\/oncotarget.16181","article-title":"Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells","volume":"8","author":"Galbiati","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.156011_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/MCB.00444-09","article-title":"Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1\u03b1 enhances hypoxic gene expression and tumor growth","volume":"30","author":"Krieg","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2025.156011_bib25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijbiomac.2018.12.105","article-title":"KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion","volume":"126","author":"Liu","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2025.156011_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10258","article-title":"The KDM3A\u2013KLF2\u2013IRF4 axis maintains myeloma cell survival","volume":"7","author":"Ohguchi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156011_bib27","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1128\/MCB.00133-12","article-title":"KDM3B is the H3K9 demethylase involved in transcriptional activation of lmo2 in Leukemia","volume":"32","author":"Kim","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2025.156011_bib28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12935-019-0979-7","article-title":"KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML\/RAR\u03b1","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2025.156011_bib29","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1101\/gad.267278.115","article-title":"JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors","volume":"29","author":"Chen","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2025.156011_bib30","first-page":"115","article-title":"Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling","volume":"7","author":"Cai","year":"2017","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.prp.2025.156011_bib31","first-page":"852","article-title":"Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2","volume":"8","author":"Chen","year":"2018","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.prp.2025.156011_bib32","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-12-4300","article-title":"KDM4\/JMJD2 histone demethylases: epigenetic regulators in cancer cells","volume":"73","author":"Berry","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2025.156011_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbrc.2007.05.179","article-title":"Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D","volume":"359","author":"Shin","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2025.156011_bib34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI78132","article-title":"Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1","volume":"126","author":"Kim","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2025.156011_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2014.04.126","article-title":"JMJD2A predicts prognosis and regulates cell growth in human gastric cancer","volume":"449","author":"Hu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2025.156011_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017830","article-title":"Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development","volume":"6","author":"Kawazu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prp.2025.156011_bib37","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.7150\/thno.38087","article-title":"JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy","volume":"10","author":"Tan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2025.156011_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cell.2013.06.051","article-title":"KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors","volume":"154","author":"Black","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156011_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv080","article-title":"The role of histone demethylase KDM4B in Myc signaling in neuroblastoma","volume":"107","author":"Yang","year":"2015","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2025.156011_bib40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","article-title":"Cooperative epigenetic modulation by cancer amplicon genes","volume":"18","author":"Rui","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2025.156011_bib41","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1038\/onc.2009.297","article-title":"Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer","volume":"28","author":"Liu","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156011_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1217394109","article-title":"Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression","volume":"109","author":"Luo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156011_bib43","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1101\/gad.280495.116","article-title":"Jmjd2\/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells","volume":"30","author":"Agger","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2025.156011_bib44","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1038\/s41388-020-01483-w","article-title":"Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression","volume":"39","author":"Peng","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156011_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-018-0861-6","article-title":"Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1\u03b2\/VEGFA signalling","volume":"17","author":"Hu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2025.156011_bib46","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.7150\/thno.45581","article-title":"Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2025.156011_bib47","article-title":"Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D\/KDM4D","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prp.2025.156011_bib48","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mc.23724","article-title":"Baicalein promotes KDM4E to induce BICD1 and inhibit triple-negative breast cancer progression by blocking PAR1 signaling","volume":"63","author":"Dong","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.prp.2025.156011_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13046-020-01735-3","article-title":"Activation of the KDM5A\/miRNA-495\/YTHDF2\/m6A-MOB3B axis facilitates prostate cancer progression","volume":"39","author":"Du","year":"2020","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2025.156011_bib50","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1158\/0008-5472.CAN-12-3165","article-title":"Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis","volume":"73","author":"Teng","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2025.156011_bib51","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1038\/s41598-019-44733-y","article-title":"Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications","volume":"9","author":"Kumar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156011_bib52","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.celrep.2016.05.046","article-title":"PI3K\/AKT signaling regulates H3K4 methylation in breast cancer","volume":"15","author":"Spangle","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2025.156011_bib53","article-title":"Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212","volume":"8","author":"Liang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prp.2025.156011_bib54","doi-asserted-by":"crossref","first-page":"19226","DOI":"10.1073\/pnas.0700735104","article-title":"JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer","volume":"104","author":"Xiang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156011_bib55","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ccr.2014.04.024","article-title":"JARID1B is a luminal lineage-driving oncogene in breast cancer","volume":"25","author":"Yamamoto","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2025.156011_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13148-018-0533-9","article-title":"Histone demethylase JARID1B\/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor","volume":"10","author":"Kuo","year":"2018","journal-title":"Clin. Epigenet"},{"key":"10.1016\/j.prp.2025.156011_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13046-016-0311-5","article-title":"Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27","volume":"35","author":"Wang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2025.156011_bib58","first-page":"1366","article-title":"Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells","volume":"22","author":"Huang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2025.156011_bib59","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.7150\/thno.60233","article-title":"Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis","volume":"11","author":"Zheng","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2025.156011_bib60","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3389\/fonc.2020.01025","article-title":"KDM5C represses FASN-mediated lipid metabolism to exert tumor suppressor activity in intrahepatic cholangiocarcinoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2025.156011_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.535449","article-title":"KDM5c promotes colon cancer cell proliferation through the FBXW7-c-Jun regulatory axis","volume":"10","author":"Lin","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2025.156011_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004635","article-title":"The dual function of KDM5C in both gene transcriptional activation and repression promotes breast cancer cell growth and tumorigenesis","volume":"8","author":"Shen","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.prp.2025.156011_bib63","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-15-0906","article-title":"JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2025.156011_bib64","doi-asserted-by":"crossref","first-page":"12247","DOI":"10.1002\/jcb.27308","article-title":"KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male","volume":"120","author":"Shen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2025.156011_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91907-8","article-title":"Y disruption, autosomal hypomethylation and poor male lung cancer survival","volume":"11","author":"Willis-Owen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156011_bib66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ng.349","article-title":"Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer","volume":"41","author":"Van Haaften","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2025.156011_bib67","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1038\/ncomms4630","article-title":"The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes","volume":"5","author":"Huether","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156011_bib68","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156011_bib69","article-title":"KDM6A suppresses hepatocellular carcinoma cell proliferation by negatively regulating the TGF\u2011\u03b2\/SMAD signaling pathway","author":"Li","year":"2020","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.prp.2025.156011_bib70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cam4.3602","article-title":"Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer","volume":"10","author":"Chen","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2025.156011_bib71","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41388-020-01449-y","article-title":"Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3","volume":"39","author":"Leng","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156011_bib72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature13605","article-title":"Contrasting roles for histone 3 lysine 27 demethylases in acute lymphoblastic leukemia","volume":"514","author":"Ntziachristos","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.156011_bib73","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/ijc.31843","article-title":"Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer","volume":"143","author":"Lee","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2025.156011_bib74","article-title":"The Jumonji domain-containing histone demethylase homolog 1D\/lysine demethylase 7A (JHDM1D\/KDM7A) is an epigenetic activator of RHOJ transcription in breast cancer cells","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.prp.2025.156011_bib75","doi-asserted-by":"crossref","first-page":"20725","DOI":"10.1073\/pnas.1108462109","article-title":"Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis","volume":"108","author":"Osawa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156011_bib76","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/0008-5472.CAN-16-2350","article-title":"Histone demethylase PHF8 promotes progression and metastasis of gastric cancer","volume":"7","author":"Li","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2025.156011_bib77","doi-asserted-by":"crossref","first-page":"24859","DOI":"10.1073\/pnas.1919766117","article-title":"Targeting the histone demethylase PHF8-mediated PKC\u03b1-Src-PTEN axis in HER2-negative gastric cancer","volume":"117","author":"Tseng","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156011_bib78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13046-018-0890-4","article-title":"PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma","volume":"37","author":"Zhou","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2025.156011_bib79","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/onc.2014.219","article-title":"PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer","volume":"34","author":"Lee","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156011_bib80","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.biopha.2018.07.144","article-title":"Down-regulation of JMJD5 suppresses metastasis and induces apoptosis in oral squamous cell carcinoma by regulating p53\/NF-\u03baB pathway","volume":"109","author":"Yao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2025.156011_bib81","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1073\/pnas.1000401107","article-title":"KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation","volume":"107","author":"Hsia","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156011_bib82","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.21873\/anticanres.13806","article-title":"The histone demethylase NO66 induces glioma cell proliferation","volume":"39","author":"Wang","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prp.2025.156011_bib83","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1245\/s10434-016-5395-9","article-title":"Clinical significance of histone demethylase NO66 in invasive colorectal cancer","volume":"24","author":"Nishizawa","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2025.156011_bib84","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/onc.2016.208","article-title":"MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation","volume":"36","author":"Huang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156011_bib85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.156011_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118002","article-title":"LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibition","volume":"10","author":"Nagasawa","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prp.2025.156011_bib87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41598-017-17913-x","article-title":"LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer","volume":"8","author":"Boulding","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156011_bib88","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/cancers11101585","article-title":"The histone demethylase LSD1\/\u039aDM1A mediates chemoresistance in breast cancer via regulation of a stem cell program","volume":"11","author":"Verigos","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156011_bib89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2017.03.038","article-title":"Targeting KDM1A attenuates Wnt\/\u03b2-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma","volume":"398","author":"Huang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2025.156011_bib90","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbrc.2019.03.154","article-title":"Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells","volume":"512","author":"Wu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2025.156011_bib91","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/ijms20102443","article-title":"Promotion of cell death in cisplatin-resistant ovarian cancer cells through KDM1B-DCLRE1B modulation","volume":"20","author":"Lee","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.prp.2025.156011_bib92","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/onc.2016.320","article-title":"Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance","volume":"36","author":"Ramadoss","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156011_bib93","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-20-0233","article-title":"p300-mediated acetylation of histone demethylase JMJD1A prevents its degradation by ubiquitin ligase STUB1 and enhances its activity in prostate cancer","volume":"80","author":"Xu","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2025.156011_bib94","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10120-019-01024-9","article-title":"JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8","volume":"23","author":"Nakagawa","year":"2020","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.prp.2025.156011_bib95","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/15384047.2021.2020060","article-title":"Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC\/Cdh1-dependent degradation of CtIP and PAF15","volume":"23","author":"Duan","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2025.156011_bib96","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1080\/15384101.2015.1090063","article-title":"The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma","volume":"14","author":"Banelli","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prp.2025.156011_bib97","first-page":"247","article-title":"Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer","volume":"4","author":"Hou","year":"2012","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.prp.2025.156011_bib98","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.3892\/mmr.2017.6960","article-title":"KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance","volume":"16","author":"Feng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2025.156011_bib99","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.7150\/ijbs.25881","article-title":"KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance","volume":"14","author":"Xu","year":"2018","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.prp.2025.156011_bib100","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.biopha.2018.08.041","article-title":"KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1","volume":"107","author":"Lin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2025.156011_bib101","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1073\/pnas.1600420113","article-title":"Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression","volume":"113","author":"Komura","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2025.156011_bib102","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3892\/ol.2022.13485","article-title":"KDM5B expression in cisplatin resistant neuroblastoma cell lines","volume":"24","author":"Belhajova","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2025.156011_bib103","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/cancers11060878","article-title":"Targeting of histone demethylases KDM5A and KDM6B inhibits the proliferation of temozolomide-resistant glioblastoma cells","volume":"11","author":"Romani","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156011_bib104","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.7150\/thno.50571","article-title":"KDM6A promotes imatinib resistance through YY1-mediated transcriptional upregulation of TRKA independently of its demethylase activity in chronic myelogenous leukemia","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2025.156011_bib105","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1002\/ijc.31750","article-title":"GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells","volume":"143","author":"Chen","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2025.156011_bib106","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3324\/haematol.2016.144964","article-title":"Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs","volume":"102","author":"Mathur","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2025.156011_bib107","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41419-020-03279-y","article-title":"JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma","volume":"11","author":"Macedo-Silva","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2025.156011_bib108","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/ijo.2022.5393","article-title":"Targeting histone demethylases as a potential cancer therapy (Review)","volume":"61","author":"Diao","year":"2022","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.prp.2025.156011_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154911","article-title":"ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer","volume":"252","author":"Deng","year":"2023","journal-title":"Pathol. Res Pract."},{"key":"10.1016\/j.prp.2025.156011_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154461","article-title":"Downregulated KDM6A mediates gastric carcinogenesis via Wnt\/\u03b2-catenin signaling pathway mediated epithelial-to-mesenchymal transition","volume":"245","author":"Feng","year":"2023","journal-title":"Pathol. Res Pract."},{"key":"10.1016\/j.prp.2025.156011_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154688","article-title":"Epigenetic drugs as new emerging therapeutics: what is the scale's orientation of application and challenges?","volume":"248","author":"Farani","year":"2023","journal-title":"Pathol. Res Pract."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:27:10Z","timestamp":1778747230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":111,"alternative-id":["S0344033825002031"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156011","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysine demethylases and cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156011"}}